Combining Circulating Tumour DNA with Clinical Pathological Risk Factors for Developing Peritoneal Metastasis Prediction Model in Patients with Colorectal Cancer
British Journal of Hospital Medicine · 2025
DOI: 10.12968/hmed.2024.0704 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Hospital Medicine, 2025. Verfasst von Bohan Han und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Peritoneal Neoplasms, Circulating Tumor DNA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Abstract (Originalsprache)
Aims/Background Peritoneal metastasis in colorectal cancer (CRC) indicates a poor prognosis for patients. Circulating tumour DNA (ctDNA) effectively predicts recurrence and metastasis. Therefore, this study aims to construct a predictive model for peritoneal metastasis by integrating ctDNA with clinicopathological factors in stage I–III CRC patients.
Methods
We conducted a retrospective analysis of 299 CRC patients who underwent ctDNA detection at The Sixth Affiliated Hospital, Sun Yat-sen University between January 2010 and December 2022. Patients were randomly divided into training (n = 209) and validation (n = 90) sets in a 7:3 ratio using a random number table method. The least absolute shrinkage and selection operator (LASSO) regression model optimized feature selection, and multivariable logistic regression constructed the predictive model.
Results
Among the study cohort, 59 patients were ctDNA-positive. Postoperative ctDNA positivity was associated with an 8.522-fold increased risk of peritoneal metastasis (p < 0.001, odds ratio (OR) 8.522, 95% confidence interval (CI) 4.371–16.615). The model included preoperative carbohydrate antigen 125 (CA-125), pathological lymph node staging, perineural invasion, and ctDNA levels, achieving an area under the curve (AUC) of 0.808 (95% CI 0.727–0.888) in the training set and 0.784 (95% CI 0.658–0.910) in the validation set.
Conclusion
This model can accurately identify high-risk patients for peritoneal metastasis in postoperative CRC, facilitating early detection and timely intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
- Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Disease, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
ORCID-Profile: Yanhong Deng
Zitieren
APA
Han, B., Hu, H., Zhang, J., Xie, X., & Deng, Y. (2025). Combining Circulating Tumour DNA with Clinical Pathological Risk Factors for Developing Peritoneal Metastasis Prediction Model in Patients with Colorectal Cancer. British Journal of Hospital Medicine. https://doi.org/10.12968/hmed.2024.0704
Vancouver
Han B, Hu H, Zhang J, Xie X, Deng Y. Combining Circulating Tumour DNA with Clinical Pathological Risk Factors for Developing Peritoneal Metastasis Prediction Model in Patients with Colorectal Cancer. British Journal of Hospital Medicine. 2025. doi:10.12968/hmed.2024.0704
BibTeX
@article{Han2025,
author = {Han, Bohan and Hu, Huabin and Zhang, Jianwei and Xie, Xiaoyu and Deng, Yanhong},
title = {Combining Circulating Tumour DNA with Clinical Pathological Risk Factors for Developing Peritoneal Metastasis Prediction Model in Patients with Colorectal Cancer},
journal = {British Journal of Hospital Medicine},
year = {2025},
doi = {10.12968/hmed.2024.0704}
}
EUVIMED